Global Information
회사소개 | 문의 | 위시리스트

세계의 감염증 진단 시장 : 규모, 점유율, 동향, 예측

Infectious Disease Diagnostics Market - Size, Share, Trends, and Forecast to 2026

리서치사 Coherent Market Insights
발행일 2018년 07월 상품 코드 677999
페이지 정보 영문
가격
US $ 4,500 ₩ 5,479,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,523,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,176,000 PPT Turned PDF (Enterprise User License)


세계의 감염증 진단 시장 : 규모, 점유율, 동향, 예측 Infectious Disease Diagnostics Market - Size, Share, Trends, and Forecast to 2026
발행일 : 2018년 07월 페이지 정보 : 영문

세계의 감염증 진단 시장을 조사했으며, 시장 개요, 제품 종류·질환·기술·검사 장소·최종사용자·지역별 시장 규모의 추이와 예측, 시장 동향, 성장요인 및 저해요인 분석, 시장 기회, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 개요

  • 리포트 개요
    • 시장 정의와 범위
  • 개요
    • 제품 종류별
    • 질환별
    • 기술별
    • 검사 장소별
    • 최종사용자별
    • 지역별
  • 시장 기회

제3장 시장 동향, 규제, 동향 분석

  • 시장 역학
    • 성장요인
    • 저해요인
    • 시장 기회
  • 영향 분석
  • PEST 분석
  • Porter의 산업 분석
  • 규제 시나리오

제4장 세계의 감염증 진단 시장 : 제품 종류별

  • 서론
  • 키트·시약
  • 장비

제5장 세계의 감염증 진단 시장 : 질환별

  • 서론
  • HIV
  • 간염
  • 의료 관련 감염(HAI)
  • 인유두종바이러스(HPV)
  • 결핵
  • 인플루엔자
  • 기타

제6장 세계의 감염증 진단 시장 : 기술별

  • 서론
  • 면역진단약
  • 중합효소 연쇄 반응(PCR)
  • 차세대 시퀀싱(NGS)
  • 기타

제7장 세계의 감염증 진단 시장 : 검사 장소별

  • 서론
  • 시험기관 검사
  • POC 검사

제8장 세계의 감염증 진단 시장 : 최종사용자별

  • 서론
  • 병원
  • 병리/진단 센터
  • 연구기관
  • 홈케어
  • 기타

제9장 세계의 감염증 진단 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 아프리카
  • 중동

제10장 경쟁 구도

  • 회사 개요
    • Danaher Corporation
    • Abbott Laboratories
    • Becton, Dickinson, and Company
    • F.Hoffmann La-Roche Ltd.
    • Trinity Biotech Plc
    • Cardinal Health, Inc.
    • BioMerieux
    • Bio-Rad Laboratories, Inc.
    • AccuBioTech Co., Ltd.
    • Acon Laboratories, Inc.

제11장 부록

  • 참고 문헌
  • 조사 방법
KSA 18.08.30

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Management of infectious diseases can be done with speedy diagnosis, implementation of preventive, and treatment strategies, and strict adherence to the treatment plan. Infectious diseases are lethal and may lead to death if not managed properly and in time. However, rapid and early diagnosis is the key in efficient management of the infectious diseases. Late diagnosis of the diseases often makes it difficult for proper management of the disease and to keep it from spreading.

As the prevalence of infectious diseases is increasing, the need of effective diagnostic tests is also increasing. Centralized laboratory testing has been the gold standard for disease diagnosis. However, emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic would be useful due to unavailability of labs, infrastructure, and trained personnel.

Market Dynamics

Technological advancements to facilitate speedy diagnosis and extensive product portfolios of infectious disease diagnostics offered by manufacturer’s supports the growth of infectious disease diagnostics market. Manufacturers are indulged in providing novel diagnostic solutions for identifying infectious diseases.

For instance, Becton Dickinson and Company launched first automated phenotypic test, BD Phoenix CPO detect test, to detect and classify carbapenemase-producing organisms (CPO) in 2017. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market.

Key features of the study:

This report provides in-depth analysis of infectious disease diagnostics market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F. Hoffmann La-Roche Ltd., Trinity Biotech Plc, Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and Acon Laboratories, Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the infectious disease diagnostics market

Detailed Segmentation:

  • Global Infectious Disease Diagnostics Market, By Product Type:
  • Kits & Reagents
  • Instruments
  • Global Infectious Disease Diagnostics Market, By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • Global Infectious Disease Diagnostics Market, By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • Global Infectious Disease Diagnostics Market, By Test Location:
  • Laboratory Testing
  • Point-of-Care Testing
  • Global Infectious Disease Diagnostics Market, By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • Global Infectious Disease Diagnostics Market, By Geography:
  • North America
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Danaher Corporation*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • Hoffmann La-Roche Ltd.
  • Trinity Biotech Plc
  • Cardinal Health, Inc.
  • BioMérieux
  • Bio-Rad Laboratories, Inc.
  • AccuBioTech Co., Ltd.
  • Acon Laboratories, Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Disease Type
    • Market Snippet, By Technology
    • Market Snippet, By Test Location
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • PEST Analysis
  • PORTER's Analysis
  • Regulatory Scenario

4. Global Infectious Disease Diagnostics Market, By Product Type, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Infectious Disease Diagnostics Market, By Disease Type, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • HIV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Hepatitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Healthcare Associated Infections (HAIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Human Papillomavirus (HPV)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Tuberculosis (TB)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Infectious Disease Diagnostics Market, By Technology, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Immunodiagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Next Generation Sequencing (NGS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Infectious Disease Diagnostics Market, By Test Location, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Laboratory Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Point of Care Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Infectious Disease Diagnostics Market, By End User, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Pathology/Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Home-Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

9. Global Infectious Disease Diagnostics Market, By Region, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

10. Competitive Landscape

  • Company Profiles
    • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Becton, Dickinson, and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • F.Hoffmann La-Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Trinity Biotech Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cardinal Health, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BioMerieux
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AccuBioTech Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Acon Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q